目的:观察CAG方案联合中药扶正解毒治疗急性髓系白血病的疗效和安全性。方法:19例急性髓系白血病患者应用CAG方案(阿糖胞苷10 mg/m2,q12 h,皮下注射,第1~14天,阿柔吡星20mg,第1,3,5,7天,粒细胞集落刺激因子200μg/m2,1次/d)联合中药扶正解毒治疗。观察患者疗效及不良反应。结果:19例AML患者,临床有效14例(73.4%),其中完全缓解11例(57.9%),部分缓解3例(15.8%),无效5例(26.3%)。结论:CAG方案联合中药扶正解毒治疗急性髓系白血病疗效可靠,不良反应少,安全性高,化疗相关死亡率低。 Objective: To observe the efficacy and safety of CAG regimen combined with Chinese medicine Fuzheng detoxification in the treatment of acute myeloid leukemia. Methods: Nineteen patients with acute myeloid leukemia were treated with CAG regimen (cytarabine 10 mg / m2, q12 h, subcutaneously on days 1 to 14, adefovir dipivoxil 20 mg, on days 1, Granulocyte colony-stimulating factor 200μg / m2, 1 time / d) combined with traditional Chinese medicine Fuzheng detoxification treatment. Observed the efficacy and adverse reactions of patients. Results: Of the 19 patients with AML, 14 were clinically effective (73.4%), of which 11 were complete remission (57.9%), 3 were remission (15.8%) and 5 were ineffective (26.3%). Conclusion: CAG regimen combined with Fuzheng detoxication in the treatment of acute myeloid leukemia has reliable curative effect, less adverse reactions, high safety and low chemotherapy-related mortality.